The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetes Software Market Research Report 2024
Synopsis
Diabetes software can include aggregate and analytical views of diabetes data. These views include:
– Calendar views that display glucose trends and compare them to patient’s insulin intake.
– Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.
– Listing of contextual and lifestyle data such as patient’s carb intake.
– Insulin data that includes pie charts showing the ratio of basal to bolus rates.
– General data tables that show average blood glucose rates bucketed into different time periods
– And more.
More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.
The global Diabetes Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Software.
Report Scope
The Diabetes Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
Segment by Type
For Smartphones
For Tablet PC
Web-based
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Diabetes software can include aggregate and analytical views of diabetes data. These views include:
– Calendar views that display glucose trends and compare them to patient’s insulin intake.
– Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.
– Listing of contextual and lifestyle data such as patient’s carb intake.
– Insulin data that includes pie charts showing the ratio of basal to bolus rates.
– General data tables that show average blood glucose rates bucketed into different time periods
– And more.
More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.
The global Diabetes Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Software.
Report Scope
The Diabetes Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
Segment by Type
For Smartphones
For Tablet PC
Web-based
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 For Smartphones
1.2.3 For Tablet PC
1.2.4 Web-based
1.3 Market by Application
1.3.1 Global Diabetes Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Software Market Perspective (2019-2030)
2.2 Diabetes Software Growth Trends by Region
2.2.1 Global Diabetes Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetes Software Historic Market Size by Region (2019-2024)
2.2.3 Diabetes Software Forecasted Market Size by Region (2025-2030)
2.3 Diabetes Software Market Dynamics
2.3.1 Diabetes Software Industry Trends
2.3.2 Diabetes Software Market Drivers
2.3.3 Diabetes Software Market Challenges
2.3.4 Diabetes Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Software Players by Revenue
3.1.1 Global Top Diabetes Software Players by Revenue (2019-2024)
3.1.2 Global Diabetes Software Revenue Market Share by Players (2019-2024)
3.2 Global Diabetes Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Software Revenue
3.4 Global Diabetes Software Market Concentration Ratio
3.4.1 Global Diabetes Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Software Revenue in 2023
3.5 Diabetes Software Key Players Head office and Area Served
3.6 Key Players Diabetes Software Product Solution and Service
3.7 Date of Enter into Diabetes Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Software Breakdown Data by Type
4.1 Global Diabetes Software Historic Market Size by Type (2019-2024)
4.2 Global Diabetes Software Forecasted Market Size by Type (2025-2030)
5 Diabetes Software Breakdown Data by Application
5.1 Global Diabetes Software Historic Market Size by Application (2019-2024)
5.2 Global Diabetes Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetes Software Market Size (2019-2030)
6.2 North America Diabetes Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetes Software Market Size by Country (2019-2024)
6.4 North America Diabetes Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Software Market Size (2019-2030)
7.2 Europe Diabetes Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetes Software Market Size by Country (2019-2024)
7.4 Europe Diabetes Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Software Market Size (2019-2030)
8.2 Asia-Pacific Diabetes Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetes Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetes Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Software Market Size (2019-2030)
9.2 Latin America Diabetes Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetes Software Market Size by Country (2019-2024)
9.4 Latin America Diabetes Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Software Market Size (2019-2030)
10.2 Middle East & Africa Diabetes Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetes Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetes Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glooko
11.1.1 Glooko Company Detail
11.1.2 Glooko Business Overview
11.1.3 Glooko Diabetes Software Introduction
11.1.4 Glooko Revenue in Diabetes Software Business (2019-2024)
11.1.5 Glooko Recent Development
11.2 Accu-Chek (Roche)
11.2.1 Accu-Chek (Roche) Company Detail
11.2.2 Accu-Chek (Roche) Business Overview
11.2.3 Accu-Chek (Roche) Diabetes Software Introduction
11.2.4 Accu-Chek (Roche) Revenue in Diabetes Software Business (2019-2024)
11.2.5 Accu-Chek (Roche) Recent Development
11.3 Tidepool
11.3.1 Tidepool Company Detail
11.3.2 Tidepool Business Overview
11.3.3 Tidepool Diabetes Software Introduction
11.3.4 Tidepool Revenue in Diabetes Software Business (2019-2024)
11.3.5 Tidepool Recent Development
11.4 LifeScan, Inc (Platinum Equity)
11.4.1 LifeScan, Inc (Platinum Equity) Company Detail
11.4.2 LifeScan, Inc (Platinum Equity) Business Overview
11.4.3 LifeScan, Inc (Platinum Equity) Diabetes Software Introduction
11.4.4 LifeScan, Inc (Platinum Equity) Revenue in Diabetes Software Business (2019-2024)
11.4.5 LifeScan, Inc (Platinum Equity) Recent Development
11.5 Pharmaco Diabetes
11.5.1 Pharmaco Diabetes Company Detail
11.5.2 Pharmaco Diabetes Business Overview
11.5.3 Pharmaco Diabetes Diabetes Software Introduction
11.5.4 Pharmaco Diabetes Revenue in Diabetes Software Business (2019-2024)
11.5.5 Pharmaco Diabetes Recent Development
11.6 Ascensia Diabetes Care Holdings AG
11.6.1 Ascensia Diabetes Care Holdings AG Company Detail
11.6.2 Ascensia Diabetes Care Holdings AG Business Overview
11.6.3 Ascensia Diabetes Care Holdings AG Diabetes Software Introduction
11.6.4 Ascensia Diabetes Care Holdings AG Revenue in Diabetes Software Business (2019-2024)
11.6.5 Ascensia Diabetes Care Holdings AG Recent Development
11.7 Diabeto Medtech India Pvt. Ltd
11.7.1 Diabeto Medtech India Pvt. Ltd Company Detail
11.7.2 Diabeto Medtech India Pvt. Ltd Business Overview
11.7.3 Diabeto Medtech India Pvt. Ltd Diabetes Software Introduction
11.7.4 Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Software Business (2019-2024)
11.7.5 Diabeto Medtech India Pvt. Ltd Recent Development
11.8 Abbott Diabetes Care
11.8.1 Abbott Diabetes Care Company Detail
11.8.2 Abbott Diabetes Care Business Overview
11.8.3 Abbott Diabetes Care Diabetes Software Introduction
11.8.4 Abbott Diabetes Care Revenue in Diabetes Software Business (2019-2024)
11.8.5 Abbott Diabetes Care Recent Development
11.9 Acon Diabetes Care International
11.9.1 Acon Diabetes Care International Company Detail
11.9.2 Acon Diabetes Care International Business Overview
11.9.3 Acon Diabetes Care International Diabetes Software Introduction
11.9.4 Acon Diabetes Care International Revenue in Diabetes Software Business (2019-2024)
11.9.5 Acon Diabetes Care International Recent Development
11.10 BIONIME
11.10.1 BIONIME Company Detail
11.10.2 BIONIME Business Overview
11.10.3 BIONIME Diabetes Software Introduction
11.10.4 BIONIME Revenue in Diabetes Software Business (2019-2024)
11.10.5 BIONIME Recent Development
11.11 Custo med
11.11.1 Custo med Company Detail
11.11.2 Custo med Business Overview
11.11.3 Custo med Diabetes Software Introduction
11.11.4 Custo med Revenue in Diabetes Software Business (2019-2024)
11.11.5 Custo med Recent Development
11.12 Dexcom
11.12.1 Dexcom Company Detail
11.12.2 Dexcom Business Overview
11.12.3 Dexcom Diabetes Software Introduction
11.12.4 Dexcom Revenue in Diabetes Software Business (2019-2024)
11.12.5 Dexcom Recent Development
11.13 Dottli
11.13.1 Dottli Company Detail
11.13.2 Dottli Business Overview
11.13.3 Dottli Diabetes Software Introduction
11.13.4 Dottli Revenue in Diabetes Software Business (2019-2024)
11.13.5 Dottli Recent Development
11.14 GlucoMe
11.14.1 GlucoMe Company Detail
11.14.2 GlucoMe Business Overview
11.14.3 GlucoMe Diabetes Software Introduction
11.14.4 GlucoMe Revenue in Diabetes Software Business (2019-2024)
11.14.5 GlucoMe Recent Development
11.15 MyLife
11.15.1 MyLife Company Detail
11.15.2 MyLife Business Overview
11.15.3 MyLife Diabetes Software Introduction
11.15.4 MyLife Revenue in Diabetes Software Business (2019-2024)
11.15.5 MyLife Recent Development
11.16 Nova
11.16.1 Nova Company Detail
11.16.2 Nova Business Overview
11.16.3 Nova Diabetes Software Introduction
11.16.4 Nova Revenue in Diabetes Software Business (2019-2024)
11.16.5 Nova Recent Development
11.17 Tandem Diabetes Care
11.17.1 Tandem Diabetes Care Company Detail
11.17.2 Tandem Diabetes Care Business Overview
11.17.3 Tandem Diabetes Care Diabetes Software Introduction
11.17.4 Tandem Diabetes Care Revenue in Diabetes Software Business (2019-2024)
11.17.5 Tandem Diabetes Care Recent Development
11.18 Trividia Health
11.18.1 Trividia Health Company Detail
11.18.2 Trividia Health Business Overview
11.18.3 Trividia Health Diabetes Software Introduction
11.18.4 Trividia Health Revenue in Diabetes Software Business (2019-2024)
11.18.5 Trividia Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
